ACHV
Achieve Life Sciences, Inc.
After-Market
7.82
Achieve Life Sciences, Inc. Profile
About
Info & Links
CEO
Richard Stewart
Headquarters
Vancouver, BC V6E 4H1, CANADA
Industry
Sector
Website
Auditor
PricewaterhouseCoopers LLP
Share holders
9
Employees
28
Achieve Life Sciences, Inc. Statistics
Valuation Measures
Market Capitalization2
804.90M
Enterprise Value
773.27M
Enterprise Value/EBITDA(ttm)
-13.33
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-511.12%
Return on Invested Capital(ttm)
906.07%
Return on Assets(ttm)
-82.35%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-57.99M
Net Income Available to Common(ttm)
-114.04M
Diluted EPS(ttm)
-1.55
Share Statistics
Beta (5Y Monthly)
2.25
52-Week Change
144.81%
S&P 500 52-Week Change
19.38%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
102.90M
Dividend Yield
0.00%
Float4
101.05M
% Held by Insiders
1.80%
% Held by Institutions
33.52%
Balance Sheet
Total Cash(mrq)
187.30M
Total Cash Per Share(mrq)
1.82
Total Debt(mrq)
16.32M
Total Debt/Equity(mrq)
-111.20%
Current Ratio(mrq)
0.95%
Quick Ratio(mrq)
0.95%
Book Value Per Share(mrq)
-0.14
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.19
Free Cash Flow(ytd)
-17.73M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.